Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases

Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases

Immunosuppressant conditions such as hematological malignancies increase the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It has been described in the literature that patients on anti-CD20 maintenance therapies for lymphoid malignancies are susceptible to having re...

Full description

Bibliographic Details
Main Authors: Carlos Martínez-Chinchilla, Lucía Vazquez-Montero, Natalia Palazón-Carrión, Isabel M. Fernández-Román, José López-Barba, Luis de la Cruz-Merino, Jesús Rodríguez-Baño, Zaira R. Palacios-Baena
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
COVID-19
immunocompromised
anti-CD20
rituximab
lymphoma
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.860891/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.860891/full

Similar Items